Ex-vivo Kidney Machine Perfusion: Therapeutic Potential
- PMID: 35004787
- PMCID: PMC8741203
- DOI: 10.3389/fmed.2021.808719
Ex-vivo Kidney Machine Perfusion: Therapeutic Potential
Abstract
Kidney transplantation remains the gold standard treatment for patients suffering from end-stage kidney disease. To meet the constantly growing organ demands grafts donated after circulatory death (DCD) or retrieved from extended criteria donors (ECD) are increasingly utilized. Not surprisingly, usage of those organs is challenging due to their susceptibility to ischemia-reperfusion injury, high immunogenicity, and demanding immune regulation after implantation. Lately, a lot of effort has been put into improvement of kidney preservation strategies. After demonstrating a definite advantage over static cold storage in reduction of delayed graft function rates in randomized-controlled clinical trials, hypothermic machine perfusion has already found its place in clinical practice of kidney transplantation. Nevertheless, an active investigation of perfusion variables, such as temperature (normothermic or subnormothermic), oxygen supply and perfusate composition, is already bringing evidence that ex-vivo machine perfusion has a potential not only to maintain kidney viability, but also serve as a platform for organ conditioning, targeted treatment and even improve its quality. Many different therapies, including pharmacological agents, gene therapy, mesenchymal stromal cells, or nanoparticles (NPs), have been successfully delivered directly to the kidney during ex-vivo machine perfusion in experimental models, making a big step toward achievement of two main goals in transplant surgery: minimization of graft ischemia-reperfusion injury and reduction of immunogenicity (or even reaching tolerance). In this comprehensive review current state of evidence regarding ex-vivo kidney machine perfusion and its capacity in kidney graft treatment is presented. Moreover, challenges in application of these novel techniques in clinical practice are discussed.
Keywords: ex-vivo machine perfusion; ex-vivo therapy; graft preservation; graft rejection; ischemia-reperfusion injury; kidney preconditioning; kidney transplantation; organ regeneration.
Copyright © 2021 Zulpaite, Miknevicius, Leber, Strupas, Stiegler and Schemmer.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Liver graft preservation methods during cold ischemia phase and normothermic machine perfusion.World J Gastrointest Surg. 2019 Mar 27;11(3):126-142. doi: 10.4240/wjgs.v11.i3.126. World J Gastrointest Surg. 2019. PMID: 31057698 Free PMC article. Review.
-
Ex vivo machine perfusion for renal graft preservation.Transplant Rev (Orlando). 2018 Jan;32(1):1-9. doi: 10.1016/j.trre.2017.04.002. Epub 2017 Apr 26. Transplant Rev (Orlando). 2018. PMID: 28483273 Review.
-
Transplanting Marginal Organs in the Era of Modern Machine Perfusion and Advanced Organ Monitoring.Front Immunol. 2020 May 12;11:631. doi: 10.3389/fimmu.2020.00631. eCollection 2020. Front Immunol. 2020. PMID: 32477321 Free PMC article. Review.
-
Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials.Front Immunol. 2021 Jul 6;12:673562. doi: 10.3389/fimmu.2021.673562. eCollection 2021. Front Immunol. 2021. PMID: 34295329 Free PMC article. Review.
-
Mesenchymal Stromal Cells as Anti-Inflammatory and Regenerative Mediators for Donor Kidneys During Normothermic Machine Perfusion.Stem Cells Dev. 2017 Aug 15;26(16):1162-1170. doi: 10.1089/scd.2017.0030. Epub 2017 Jun 26. Stem Cells Dev. 2017. PMID: 28557562 Review.
Cited by
-
Video analysis of ex vivo beating hearts during preservation on the TransMedics® organ care system.Front Cardiovasc Med. 2023 Jun 20;10:1216917. doi: 10.3389/fcvm.2023.1216917. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37408655 Free PMC article.
-
A Guide to the Implementation and Design of Ex Vivo Perfusion Machines for Vascularized Composite Allotransplantation.Plast Reconstr Surg Glob Open. 2024 Nov 12;12(11):e6271. doi: 10.1097/GOX.0000000000006271. eCollection 2024 Nov. Plast Reconstr Surg Glob Open. 2024. PMID: 39534373 Free PMC article.
-
Pushing the boundaries of innovation: the potential of ex vivo organ perfusion from an interdisciplinary point of view.Front Cardiovasc Med. 2023 Oct 12;10:1272945. doi: 10.3389/fcvm.2023.1272945. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37900569 Free PMC article. Review.
-
Engineered ATP-Loaded Extracellular Vesicles Derived from Mesenchymal Stromal Cells: A Novel Strategy to Counteract Cell ATP Depletion in an In Vitro Model.Int J Mol Sci. 2025 Apr 5;26(7):3424. doi: 10.3390/ijms26073424. Int J Mol Sci. 2025. PMID: 40244293 Free PMC article.
-
Progress and Setbacks in Translating a Decade of Ferroptosis Research into Clinical Practice.Cells. 2022 Jul 6;11(14):2134. doi: 10.3390/cells11142134. Cells. 2022. PMID: 35883577 Free PMC article. Review.
References
-
- Eurotransplant–Statistics. (2020). Available online at: https://statistics.eurotransplant.org/index.php?search_type=waiting+list... (accessed November 22, 2021).
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources